M. tuberculosis Gram + ve , aerobic acid fast bacilli. Resistant to disinfectant ,detergent & common antibiotics. Capable of intracellular growth. Person to person spread is by aerosol. Human are the only natural reservoir. Disease is most common in south east A sia , sub S aharan region, eastern E urope .
Treatment The two aims of TB treatment are (1) to prevent morbidity and death by curing TB while preventing the emergence of drug resistance. (2) to interrupt transmission by rendering patients non-infectious.
Uses of First Line Drugs Bactericidal activity ( i.e , their ability to rapidly reduce the number of viable organisms and render patients non-infectious) S terilizing activity ( i.e , their ability to kill all bacilli and thus sterilize the affected tissues, measured in terms of the ability to prevent relapses) Low rate of induction of drug resistance by selection of mutant bacilli.
Isoniazid (INH) Mechanism : Inhibits synthesis of mycolic acids, an essential component of mycobacterial cell walls. Indications : Active & Latent TB. Effects : Bactericidal against actively diving M. tuberculosis and Bacteriostatic against resting bacteria. Contraindications : Hypersensitive reactions, Acute Liver Disease
Precautions : Renal impairment, Hepatic impairment, Alcoholism, Severe malnutrition, Diabetes, HIV (Pyridoxine is used as prophylaxis ) Adverse Effects : Peripheral Neuropathy, Hepatotoxicity, CNS toxicity, Rash, Haemolytic anemia, Thrombocytopenia, Lupus like Syndrome, Gynecomastia . Biological half-life : 0.5-1.6h (fast acetylators ), 2-5h (slow acetylators )
Rifampin Mechanism : Inhibits RNA synthesis in bacteria. Indications : TB, MRSA, Mycobacterial infections, Prophylaxics of meningitis & epiglottitis Effects : Bactericidal, Sterilizing agent Contraindications : Allergy, Concomitant administration of live bacterial vaccines, patients receiving ritonavir-boosted saquinavir , because of increased risk of severe hepatocellular toxicity, Jaundice, Renal Failure, Hemolytic anemia , Thrombocytopenic purpura
Precaution s: May decrease the effectiveness of oral contraceptive pills (OCPs ), Type 2 Diabetes, Discontinue therapy if patient develops any signs of hepatocellular damage, including hyperbilirubinemia , Alcoholism Adverse Effects : Increased Hepatic Enzymes (CYP450), GI symptoms, Rash, Orange-Red discoloration of body fluids, Flu like syndrome (with irregular dosing) Biological Half life : 3-4 hr (prolonged in hepatic impairment); in end-stage renal disease, 1.8-11 hr
Pryazinamide Mechanism : Requires acid pH for activity. Active both intra/extracellular (Very active in first 2 months of therapy) Indication : TB Effect : bactericidal, Sterilizing action (reduces risk of relapse). Allows for shorter duration of treatment (6 months) Contraindications : Acute Gout, Hepatic Impairement , Renal Impairment ( Crcl <25ml/min) Precaution s: Alcoholism (perform routine liver function tests)
Streptomycin Effects : Bactericidal Indications : used in strains resistant to other anti-tubercular drugs or when other drugs are contraindicated Contraindications : Hypersentivity Precautions : Vestibular disturbances, Myasthenia gravis, Renal impairment, Elderly Adverse effects : Fever, Rash, Sterile abscess at injection site, tinnitus, vestibular toxicity, albuminuria, aplastic anemia (rare)
Directly Observed Treatment (DOT) T uberculosis control strategy recommended by the World Health Organization . DOT involves TB nurses, outreach volunteers or trained volunteers meeting regularly with patients to watch them take their medication. Standard short course regimen (up to 6 months)
Uses of Second Line Drugs In case of resistance to first-line agents In case of failure of clinical response to conventional therapy I n case of serious treatment-limiting adverse drug reactions